Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.

The "Spatial OMICS Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Spatial OMICS Market, valued at USD ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

As of December 6, 2025, the average one-year price target for 10x Genomics is $16.86/share. The forecasts range from a low of $14.14 to a high of $21.00. The average price target represents an ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks. On December 15, 2025, ...

BofA analyst Michael Ryskin raised the firm’s price target on 10x Genomics (TXG) to $18 from $15 and keeps a Neutral rating on the shares. The firm is updating it price targets for Life Sciences & ...

In 1950, when computing was little more than automated arithmetic and simple logic, Alan Turing asked a question that still reverberates today: can machines think? It took remarkable imagination to ...

A published image of a 10X prototype in Bordeaux appears to show ground tests underway According to sources, the Dassault Falcon 10X is expected to begin flight testing in 2026.